Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Skin Cancer|Skin Diseases
Interventions: DRUG: Quantum dots coated with veldoreotide|DRUG: Topical approved placebo
Sponsor: Al-Azhar University